UNITED STATES
               SECURITIES AND EXCHANGE COMMISSION
                       WASHINGTON, DC 20549

                             FORM 10-K


(MARK ONE)
[X]   ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED OCTOBER 30, 2010.

[ ]   TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES
      EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM  ____ TO ____.

                      COMMISSION FILE NUMBER: 0-1455


                        OPT-SCIENCES CORPORATION
         (Exact name of registrant as specified in its charter)

         NEW JERSEY                             21-0681502
(State or other jurisdiction of               (I.R.S. Employer
incorporation or organization)              Identification No.)

    1912 BANNARD STREET, CINNAMINSON, NEW JERSEY             08077
     (Address of principal executive offices)              (Zip Code)


                           (856)829-2800
          (Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act:

                   Common Stock, $.25 par value per share
                                (Title of Class)

Indicate by check mark if the registrant is a well seasoned issuer, as defined
in Rule 405 of the Securities Act. YES[  ] NO[X]

Indicate by check mark if the registrant is not required to file reports
pursuant to Section 13 or 15(d) of the Exchange Act. YES[    ]  NO[ X ]

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to
such filing requirements for the past 90 days. YES[X]   NO [   ]

Indicate by check mark whether the registrant has submitted electronically and
posted on its corporate Website, if any, every Interactive Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T('232.405 of
this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files). YES[X] NO[   ]


                                   1



Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K('229.405 of this chapter) is not contained herein, and will
not be contained, to the best of registrant's knowledge, in definitive proxy
or information statements incorporated by reference in Part III of this Form
10-K or any amendment to this Form 10-K.  [X]

Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company.
See the definitions of 'large accelerated filer','accelerated filer' and
'smaller reporting company' in Rule 12b-2 of the Exchange Act.

	Large accelerated filer              [ ]   Accelerated filer         [ ]
	Non-accelerated filer(Do not check   [ ]   Smaller reporting company [X]
       if smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined
in Rule 12b-2 of the Act). YES[ ] NO[X]

The aggregate market value of the 293,945 common shares held by non-affiliates
(i.e., excluding shares held by officers, directors and each person owning 5%
or more of the outstanding stock) as of the end of the last business day of
the registrant's most recently completed second fiscal quarter was $3,439,157
based on the highest bid price of the stock of $11.70 as quoted by the Pink
Sheets, in the Non-NASDAQ over the counter market.

Indicate the number of shares outstanding of each of the registrant's classes
of common stock, as of the latest practicable date: 775,585 shares of the
registrant's common stock, par value of $.25, were outstanding on December 31,
2010.

                  DOCUMENTS INCORPORATED BY REFERENCE

None.




                                  2



              OPT-SCIENCES CORPORATION AND SUBSIDIARY
             FORM 10-K ANNUAL REPORT - FISCAL YEAR 2010

                         TABLE OF CONTENTS

                                                                  Page

           PART I

Item 1.    Business . . . . . . . . . . . . . . . . . . . . . . . . 4
Item 1A.   Risk Factors  . .  . . . . . . . . . . . . . . . . . . . 6
Item 1B.   Unresolved Staff Comments . . .. . . . . . . . . . . . . 6
Item 2.    Properties . . . . . . . . . . . . . . . . . . . . . . . 7
Item 3.    Legal Proceedings  . . . . . . . . . . . . . . . . . . . 7
Item 4.    (Removed and Reserved) . . . . . . . . . . . . . . . . . 7

           PART II
Item 5.    Market for Registrant's Common Equity, Related
           Stockholder Matters and Issuer Purchases of Equity
           Securities . . . . . . . . . . . . . . . . . . . . . . . 7
Item 6.    Selected Financial Data . . . . . .  . . . . . . . . . . 8
Item 7.    Management's Discussion and Analysis of Financial
           Conditions and Results of Operations   . . . . . . . . . 8
Item 7A.   Quantitative and Qualitative Disclosures
           About Market Risk  . . . . . . . . . . . . . . . . . . . 11
Item 8.    Financial Statements and Supplementary Data. . . . . . . 11
Item 9.    Changes In and Disagreements with Accountants on
           Accounting and Financial Disclosure. . . . . . . . . . . 11
Item 9A.   Controls and Procedures. . . . . . . . . . . . . . . . . 11
Item 9B.   Other Information. . . . . . . . . . . . . . . . . . . . 12

           PART III
Item 10.   Directors, Executive Officers and Corporate Governance . 12
Item 11.   Executive Compensation . . . . . . . . . . . . . . . . . 13
Item 12.   Security Ownership of Certain Beneficial Owners and
           Management and Related Stockholder Matters . . . . . . . 14
Item 13.   Certain Relationships and Related Transactions, and
           Director Independence. . . . . . . . . . . . . . . . . . 15
Item 14.   Principal Accountant Fees and Services . . . . . . . . . 15

           PART IV
Item 15.   Exhibits, Financial Statement Schedules. . . . . . . . . 16
           Signatures . . . . . . . . . . . . . . . . . . . . . . . 16
           Section 302 Certification. . . . . . . . . . . . . . . . 18
           Section 906 Certification. . . . . . . . . . . . . . . . 19


                                   3




PART I

Special Note Regarding Forward Looking Statements

Certain sections of this annual report contain forward-looking statements.
These statements relate to future events or future financial performance and
involve known and unknown risks, uncertainties and other factors that may
cause the Company's or its industry's actual results, levels of activity,
performance or achievements to be materially different from the future
results, levels of activity, performance or achievements expressed or implied
by the forward-looking statements.

In some cases, you can identify forward-looking statements by words such as
"may," "will," "should," "expects," "plans," "anticipates," "believes,"
"estimates," "predicts," "potential," or the negative of these terms or other
comparable words. These statements are only predictions. Actual events or
results may differ materially.

Although the Company believes that the expectations reflected in the forward-
looking statements are reasonable, it cannot guarantee future results, levels
of activity, performance or achievements. Moreover, neither the Company nor
any person assumes responsibility for the accuracy and completeness of these
forward- looking statements. The Company is under no duty to update any of the
forward-looking statements after the date of this report to conform its prior
statements to actual results.

ITEM 1. BUSINESS

BUSINESS OF THE COMPANY.

OVERVIEW. Opt-Sciences Corporation, formed in 1956, conducts its business
through its wholly owned subsidiary, O & S Research, Inc. Both companies are
New Jersey corporations. As used in this form 10-K, the terms 'Company', "we"
or "our" refer to the combined operations of Opt-Sciences Corporation and O &
S Research, Inc.

The Company deposits anti-glare and/or transparent conductive optical coatings
on glass used primarily to cover instrument panels in aircraft cockpits. We
also provide full glass cutting, grinding and painting operations which
augment our optical coating capabilities. Most of our products are designed to
enable pilots to read aircraft instruments in direct sunlight or at night or
in covert situations using appropriate night vision filters. This is a niche
business primarily dependent on the needs of new and used aircraft for
initially installed parts, spare parts, replacements and upgrades. It requires
custom manufacturing of small lots of products to satisfy specific
requirements identified by our customers.

The Company's business is highly dependent on a robust commercial, business,
and regional aircraft market; to a lesser degree, it is also dependent on the
military aircraft market. We generally have a four to twelve week delivery
cycle depending on product complexity, available plant capacity and required
lead time for specialty raw materials such as polarizers or filter glass. Our
sales tend to fluctuate from quarter to quarter because all orders are custom
manufactured, and customer orders are generally scheduled for delivery based
on our customer's need date, not on our ability to make shipments. Since the
Company has two customers that together represent approximately 69% of sales,
any significant change in the requirements of either of those customers has a
direct impact on our revenue for any given quarter. When one of these customers
accelerates or defers a sizable order, sales for the following quarters may be
adjusted as the customer reevaluates its needs. One of our largest customers
has recently placed significantly higher levels of orders, as it transitions
its primary manufacturing facilities to a new location. That customer plans
to reduce future orders substantially as the transition process is concluded.


                                   4



Based on our understanding of the industry and the needs of our customers, we
expect to complete and ship approximately 50% of the Fiscal Year 2010 backlog
of unshipped orders before the end of the first quarter of fiscal 2011. If we
do so, we expect first quarter sales to be approximately $1,800,000. Sales
for the following quarters are expected to decline substantially as one of
our major customers mentioned above adjusts its inventories to more normal
levels.

CORE PRODUCTS. The distinguishing characteristic of our business is our
optical thin film coating capability. Almost all products which we offer
incorporate an optical coating of some type. Our primary coatings are for
aircraft cockpit display applications and consist of our anti-reflection
coating used for glare reduction and our transparent conductive coating used
for electromagnetic interference shielding. We apply either or both coatings
to different types of glass face plates which are usually mounted on the front
of liquid crystal displays (LCDs), cathode ray tubes (CRTs), light emitting
diode displays(LEDs) and electromechanical displays (EMDs).

ANCILLARY PRODUCTS AND SERVICES. In addition to coated glass described above,
we also offer a full range of other specialty instrument glass, including
night vision filter glass, circular polarizers, touchpads, glass sandwiches
for LCDs as well as other custom designed specialty glass components and
assemblies.

STRATEGY FOR THE FUTURE. The Company continues to re-evaluate and adjust
its growth strategy pertaining to sales and marketing, production facilities
and efficiencies and our staffing methods to maximize the value of our
financial and human resources.

In Fiscal Year 2010, we hired 6 production employees as sales increased over
the course of the year. For Fiscal Year 2011, we expect we expect overall
sales to match Fiscal Year 2010, beginning with a very strong first quarter
followed by weaker subsequent quarters.  We continue to see potential for
growth in our conductive coating business which is used primarily, but not
exclusively, on military platforms. We expect the anti-reflective coating
market to remain at current levels.  We believe our future success is
contingent on the timely increase of our capacity to provide conductive
coatings, satifying the needs of our current customers, securing new
customers, developing new products and providing adequate staff and
facilities to meet our requirements.

MARKETING AND SALES. Our principal sales executive is our President, who
maintains regular contact with the largest customers and continually seeks to
develop new customers. We do not currently employ the services of
manufacturers representatives or sales personnel. O & S Research, Inc. and our
products are listed in the Thomas Register. We also maintain sales websites at
osresearch.com and optsciences.com. We engage in a low cost public relations
and advertising program.  Purchasing personnel of major corporations or
governmental agencies place orders with us, based on price, delivery terms,
satisfaction of technical specifications and quality of product. Procurement
departments of customers ordinarily purchase products from us because we are
on an approved vendor list. We enhance sales prospects by providing creative
technical solutions to customer requirements. We are currently an approved
vendor for major aircraft programs. We continue to be a major supplier for the
anti-glare face plates covering the flat panel displays on the Boeing 777 and
the 737 Next Generation models of commercial aircraft and the long range
Gulfstream and Dassault Falcon business jets.  We are also an approved vendor
for instrument glass used on several military aircraft platforms including the
C5 Galaxy and the C130. In Fiscal 2010, we derived approximately 69% of our
revenues from two major customers. The loss or permanent curtailment of
business with either of these companies would have a negative impact on our
operating results.

PATENTS, TRADEMARKS AND PROPRIETARY KNOWLEDGE. We do not hold patents or have
registered trademarks. However, our customers do rely on our accumulated
experience and know-how in satisfying their instrument glass requirements.


                                   5



MANUFACTURING. Our customers commonly use LCDs for aircraft cockpit
instrumentation. Typically, a customer sends glass component drawings to us
for manufacturing. We generally cut the glass components from larger pieces
of glass which we purchase from multiple domestic sources, some on a custom
basis and some on a commodity basis.  The two largest suppliers of such
glass to us are Europtec and Corning.  We use our technology to apply a micro
thin optical non-glare and/or conductive coating to the glass. Both processes
utilize the deposit of a thin film of metal or metal oxide on the surface
of the glass. The process takes place in a heated vacuum chamber. We heat the
deposited material to over 1800 degrees Centigrade causing it to evaporate.
When the metal vapor contacts the glass, it condenses forming a very thin film
as hard as the original metal being evaporated. The thin films range in
thickness from 250 angstroms to 1500 angstroms. After quality control tests,
we ship the inspected products to our customers.

We also manufacture wedge glass lenses for electro-mechanical displays. These
lenses are manufactured from large glass sheets. The raw glass is a commodity
product which we can purchase from several glass manufacturers.  The largest
supplier of such glass to us is Schott in Germany.  We cut, grind and polish
the glass lenses and coat them with a micro-thin optical coating. We then ship
the lenses to the customer after clearance through quality control.

ENVIRONMENTAL MATTERS. We believe we are in material compliance with
applicable United States, New Jersey and local laws and regulations relating
to the protection of the environment, and we do not devote material resources
to such matters.

COMPETITION. Competition is based on product quality, price, reputation and
ability to meet delivery deadlines. The market for our products is very
competitive. The type and amount of instrument glass consumed is subject to
changes in display technology and in ongoing reduction in the number of
displays used on both new aircraft and retrofitted aircraft. Our competitors
include JDSU, Metavac, Mod A Can, Tyrolit, Schott Glass and Hoya Optics. Our
competitors generally have significantly more financial, technical and human
resources than we do. Because of this, our competitors have the capacity to
respond more quickly to emerging technologies and customer preferences and may
devote greater resources to development, promotion and sale of their products
than we can. This competition could result, and in the past has resulted, in
price reductions, reduced margins and lower market share.

EMPLOYEES. As of October 30, 2010, we employed 49 employees, of which 44 were
full time individuals and none of whom are members of organized labor. This
represents a increase of 6 full time employees from the end of Fiscal 2009.
We expect to make further adjustments to our employee levels based on changes
in the market and our specific efforts to improve efficiencies and customer
service. We believe we have a good relationship with our employees. We are
subject to the federal minimum wage and hour laws and provide various routine
employee benefits such as life and health insurance. We also provide a 401K
Plan for the benefit of all our employees; we do not have a stock option plan.
The 401K Plan includes a matching contribution from us representing $0.50 for
each $1.00 an employee contributes up to 6% of the employee's base wages.

AVAILABLE INFORMATION. We maintain a website, optsciences.com, where you may
find additional information about our Company. Additional Company filings are
also available at the Securities & Exchange Commission's website, sec.gov. On
our website, optsciences.com, we provide links to our SEC filings, to the SEC
itself, to Yahoo for the latest stock quotations, to our transfer agent,
StockTrans, and to our manufacturing subsidiary, O & S Research, Inc.

ITEM 1A. RISK FACTORS. Smaller reporting companies are not required to provide
the information required by this item.

ITEM 1B. UNRESOLVED STAFF COMMENTS. None


				    6



ITEM 2. PROPERTIES

We conduct our operations at our principal office and manufacturing facility
located in the East Riverton Section of Cinnaminson, New Jersey.  We own this
1.4 acre property in fee simple, and the property is not encumbered by any
lien or mortgage. The cinderblock and masonry facility contains approximately
11,000 square feet of manufacturing space and approximately 1,200 square feet
of office space. We also own and utilize a building containing 500 square feet
of warehouse and 7,500 square feet of manufacturing space on premises adjacent
to the main manufacturing facility. In addition, we lease on a year to year
basis 5,000 square feet in Riverton, New Jersey for general warehouse and
material storage.

ITEM 3. LEGAL PROCEEDINGS

We are subject from time to time to certain claims and litigation in the
ordinary course of business. It is the opinion of management that the outcome
of such matters will not have a material adverse effect on our combined
financial position or results of operations.

ITEM 4. (Removed and Reserved)

PART II

ITEM 5. MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS
AND ISSUER PURCHASES OF EQUITY SECURITIES

Our Common Shares are not listed on an established public trading market, but
are quoted by the Pink Sheets, in the non-NASDAQ over the counter market.  The
symbol for our shares is OPST. Only limited and sporadic trading occurs.
Subject to the foregoing qualification, the following table sets forth the
range of bid quotations, for the fiscal quarters indicated, as quoted by Pink
Sheets LLC., and reflects inter-dealer prices, without retail mark up, mark
down or commission and may not necessarily represent actual transactions.

        Fiscal 2009     Bid Price         Fiscal 2010     Bid Price

        1st Quarter    $5.55 - $8.50      1st Quarter   $ 8.35 - $11.25
        2nd Quarter    $5.25 - $6.36      2nd Quarter   $10.11 - $11.70
        3rd Quarter    $5.68 - $7.17      3rd Quarter   $10.05 - $11.61
        4th Quarter    $7.17 - $9.00      4th Quarter   $10.05 - $14.50

As of December 31, 2010 the closing bid for the Common Stock was $11.95. The
closing ask price was $13.25.  The Company had 828 stockholders of record of
its Common Stock as of December 31, 2010. This does not include the additional
beneficial owners of our common stock who held their shares in street name as
of that date.


SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

The Company does not have any equity compensation plan in place and did not
issue any equity securities to any person during Fiscal Year 2010.

DISTRIBUTIONS

We did not declare or pay any dividend on our Common Stock during Fiscal Year
2010. Although there is no prohibition on payment of dividends, we do not
anticipate the payment of dividends on our Common Stock in the foreseeable
future.


				    7



RECENT SALES OF UNREGISTERED SECURITIES

We did not sell unregistered securities during the three fiscal years ended
October 30, 2010.

REPURCHASES OF COMMON STOCK

The Company did not repurchase any of its common stock during the year ended
October 30, 2010.

ITEM 6. SELECTED FINANCIAL DATA

We are not required to supply this information because we are a smaller
reporting company.


ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS
              AND RESULTS OF OPERATIONS

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Management's discussion and analysis of financial condition and results of
operations are based upon the Company's consolidated financial statements,
which have been prepared in accordance with accounting principles generally
accepted in the United States of America ("U.S. GAAP"). The preparation of
these financial statements requires the Company to make estimates and
judgments that affect the reported amounts of assets, liabilities, revenues
and expenses. The Company bases its estimates on historical experience and on
various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent
from other sources. Actual results may differ from these estimates under
different assumptions or conditions. Specifically, inventory is estimated
quarterly and reconciled at the end of the fiscal year when a detailed audit
is conducted (also see Consolidated Financial Statements, Note 1. Summary of
Significant Accounting Policies and Note 2. Inventories).

GENERAL.

This Management's Discussion and Analysis as of October 30, 2010, should be
read in conjunction with the audited consolidated financial statements and
notes thereto set forth in this report. It also contains forward looking
statements as defined in Part I hereof.

LIQUIDITY AND CAPITAL RESOURCES.

We have sufficient liquidity and credit to fund our contemplated capital and
operating activities through Fiscal 2011.

We continue to use our working capital to finance current operations,
including equipment purchases, capital improvements, inventory, payroll and
accounts receivable.

Our cash increased during Fiscal 2010 to $8,398,276 from $7,606,849 at the end
of Fiscal 2009. This increase was due primarily to earnings from operations.
Other income increased from the prior year primarily due to the reduction in
realized losses on the sale of securities. Our total current assets increased
$866,761 to $10,257,594 in Fiscal 2010 from $9,390,833 in Fiscal 2009.

Because of changes in the marketplace and an increasingly competitive
environment, we believe it may be necessary to make future investments in new
equipment and processes to compete successfully in the aerospace and
commercial display markets.


				    8



RESULTS OF OPERATIONS: FISCAL YEAR 2010

NET SALES

Net sales of $4,899,983 for the Fiscal Year 2010 increased $18,672 or
less than 1% from Fiscal 2009.  This increase was due to the substantial
increase in demand for our products in the second half of FY 2010 from
the steep decline of the business and commercial jet market during FY
2009 and early 2010.

COST OF SALES

Cost of sales decreased $167,584 or 5% for Fiscal 2010 compared to Fiscal
2009.  Cost of sales consists of costs to manufacture the products we ship
and is comprised of raw materials, manufacturing direct labor and overhead
expenses. The overhead portion of cost of sales is primarily comprised of
salaries, medical and dental benefits, building expenses, production
supplies, and costs related to our production, inventory control and
quality departments.

OPERATING EXPENSES

Operating expenses for Fiscal 2010 were $828,583, an increase of
$48,218 or approximately 6% from Fiscal 2009. Operating expenses include
both general and administrative expenses and sales and delivery expenses.
Our general and administrative expenses consist of marketing and business
development expenses, professional expenses, salaries and benefits for
executive and administrative personnel, hiring, legal, accounting, and
other general corporate expenses.

OPERATING INCOME

Operating income increased $138,038 or approximately 28% to $627,089 in Fiscal
2010 from $489,051 in 2009.  The increase from Fiscal 2009 is primarily due
to the increase in productivity as sales rebounded from depressed levels.

OTHER INCOME

Other income for Fiscal Year 2010 was $75,293 compared to a loss of $17,557
for Fiscal Year 2009. This large improvement is mainly attributable to
recognition of fewer capital losses from the Company's portfolio of
marketable securities.

NET INCOME

Net income of $460,650 or $0.59 per share for Fiscal 2010 increased
approximately 70% from $271,780 or $0.35 per share for Fiscal 2009 as a
result of the factors described above.

BACKLOG OF ORDERS

Our backlog of unshipped orders stood at $2,412,100 at the end of Fiscal Year
2010, up $1,393,000 from the end of Fiscal Year 2009 and up $211,000 from
the end of the third quarter. Of the backlog of orders existing at year end,
we expect to deliver 50% within the first quarter of Fiscal Year 2011.

RESULTS OF OPERATIONS: FISCAL YEAR 2009

Fiscal 2009 ended with net sales of $4,881,311 an decrease of approximately
$1,867,380 or 28% over Fiscal 2008.  The significant decrease in total sales
for 2009 over 2008 was primarily due to a steep decline in demand for
business aircraft which utilize instrumentation cover glass manufactured by
the Company.  Operating expenses, including selling expenses, were $780,365
for Fiscal 2009, a decrease of $229,292 or 23% from Fiscal 2008.  Operating
income decreased $784,111 or 78% to $489,051 in Fiscal 2009 from $1,273,162
in 2008.  Other income resulted in a net loss of $17,557 primarily as a
result of recognizing $148,269 in capital losses from the Company's portfolio
of marketable securities. Net income after taxes of $271,780 or $0.35 per
share for Fiscal 2009 decreased markedly from $858,695 or $1.11 per share
for Fiscal 2008.


				    9



INFLATION

During the three year period that ended on October 30, 2010, inflation did not
have a material effect on our operating results.

OFF BALANCE SHEET ARRANGEMENTS

We do not currently have any off balance sheet arrangements.

COMPANY RISK FACTORS

An investment in our common stock involves investment risks. A prospective
investor should evaluate all information about us and the risk factors
discussed below in relation to his financial circumstances before investing in
us.

1. The market price of our common stock may fluctuate significantly. In
addition, since our common stock has been thinly traded, it is difficult
for our shareholders to sell shares of our common stock at a predictable price.

2. Any continuation of weakness in the global economy will have negative
implications for our Company. Since our products are incorporated into very
expensive new and retrofitted aircraft, the lack of strong global economy
and orderly capital markets may result in reduced demand for our products.

3. Significant quarterly fluctuations in backlog and orders challenge the
Company to adjust the scale of its activities to the demand for its products;
the larger the fluctuations, the more difficult it is to have efficient
operations.

4. Our product offerings are concentrated. During Fiscal 2010 we derived
approximately 95% of our revenues from instrument glass used for avionics
and related aerospace products.

5. Our revenues come from a limited number of customers, with approximately
69% of sales arising from two customers.  One of those customers was
recently acquired by a third party.  A related change in its principal
place of manufacturing has thus far resulted in a short term increase in
demand for our products, which we expect will be followed by a substantial
decline, as inventories in the new facility are adjusted to perceived needs.

6. For a major portion of our business, we rely on raw materials manufactured
in Japan. An interruption of supplies from Japan would have a significant
impact on sales and our ability to support our customers.

7. The Company purchases raw materials overseas.  To the extent that the
Company has entered into fixed price contracts based on U.S. Dollars and
purchases raw materials in foreign markets, the Company may experience a
reduction in profit margin as a result of a weakening American currency.

8. Our success depends on the efforts and expertise of our President,
Anderson L. McCabe. He is our chief executive officer, our chief financial
officer and our principal marketing officer. His death, disability or
termination of employment would adversely affect the future of our Company.
We do not have employment contracts with Mr. McCabe or other management
personnel. We do not maintain key man life insurance on Mr. McCabe or other
key personnel.


				   10



9. The market for our products is very competitive.

10. Purchase orders and specifications from our customers may include
extensive product warranties and contractual undertakings. Accordingly,
future claims by our customers may have an adverse effect on our future
operating results.

11. Our industry is also subject to significant risk from outside influences,
such as terrorist attacks (9/11) and biological epidemics (SARs and Avian
flu outbreaks in Asia). Other factors that may in the future influence our
industry are inflation, changes in diplomatic and trade relations with other
countries, tariffs, trade barriers and other regulatory barriers.

12.  We are controlled by our major stockholder, the Arthur John Kania Trust.
The Arthur John Kania Trust, beneficially owns approximately 66% of our
outstanding common stock.  Such concentrated control of the Company may
adversely affect the price of our common stock.  Because of the high
percentage of beneficial ownership, the Trustee of that Trust is able to
control matters requiring the vote of stockholders, including the election
of our board of directors and certain other significant corporate actions.
This control could delay, defer or prevent others from initiating a potential
merger, takeover or other change in our control, even if these actions would
benefit our other stockholders and us.  This control could adversely affect
the voting and other rights of our stockholders and could depress the market
price of our common stock.  If you acquire common stock, you may have no
effective voice in the management of the Company.


ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to supply information on
this item.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The Consolidated Financial Statements, the notes thereto, and the reports
thereon by Goff Backa, Alfera & Company, LLC. dated January 18, 2011, are
filed as part of this report starting on page 23 below.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Under the supervision and with the participation of the Company's Chief
Executive Officer and Chief Financial Officer, our management carried out
an evaluation of the effectiveness of the design and operation of the
Company's disclosure controls and procedures (as such term is defined in
Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as
of October 30, 2010. Based upon that evaluation, the Company's Chief
Executive Officer and Chief Financial Officer concluded that the Company's
disclosure controls and procedures were effective.

Management's Annual Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining an adequate
system of internal control over financial reporting, as such term is
defined in Rule 13a-15(f) of the Exchange Act.  Under the supervision of
our Chief Executive Officer and Chief Financial Officer, our management
conducted an evaluation of the effectiveness of our internal control over
financial reporting based on the framework in Internal Control-Integrated
Framework issued by the Committee of Sponsoring Organizations of the
Treadway Commission.  Based on that evaluation, management concluded that,
as of October 30, 2010, our internal control over financial reporting was
effective.


				   11



This Annual Report does not include an attestation report of the Company's
registered public accounting firm regarding internal control over
financial reporting.  Management's report was not subject to attestation
by the Company's registered public accounting firm pursuant to rules of
the Securities and Exchange Commission that permit the Company to provide
only management's report in this Annual Report.

Changes in Internal Control over Financial Reporting

No changes in the Company's internal control over financial reporting
occurred during the fourth quarter of fiscal year 2010 that have materially
affected, or are reasonably likely to materially affect, the Company's
internal control over financial reporting.

ITEM 9B.   OTHER INFORMATION

None.

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

INFORMATION REGARDING EXECUTIVE OFFICERS AND DIRECTORS

Our Directors serve until the next annual meeting of stockholders, or until
their successors have been elected. Our officers serve at the pleasure of the
Board of Directors.

Anderson L. McCabe, 55 years old, is our President, Chief Executive Officer
and Chief Financial Officer. He graduated from the University of South
Carolina in 1977 and received a B.S. in Chemical Engineering. From 1977 to
1985, he was employed by United Engineers and Constructors, Inc., a subsidiary
of Raytheon Corporation as Process Engineer with managerial responsibilities.
In 1986 he became our president. He has been director of the Company since
1987.

Arthur J. Kania, 79 years old, is our Secretary.  He is not active in our day-
to-day operations. Mr. Kania's principal occupations during the past five
years have been as Principal of Trikan Associates (real estate ownership and
management - investment firm); and as a partner of the law firm of Kania,
Lindner, Lasak and Feeney. He has been a director of the Company since 1977.

Arthur J. Kania, Jr., 55 years old, has been a director of the Company since
1987.  He is not active in our day-to-day operations. He is a principal of
Trikan Associates (real estate ownership and management-investment firm) and
vice-president of Newtown Street Road Associates (real estate ownership and
management).

SECTION 16(A)   BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

Section 16(a) of the Securities Exchange Act of 1934, as amended (the
"Exchange Act"), requires the Company's officers, directors and any person
owning ten percent or more of the Company's common stock, to file in their
personal capacities initial statements of beneficial ownership, statements
of change in beneficial ownership and annual statements of beneficial
ownership with the Securities and Exchange Commission (the "SEC"). Persons
filing such beneficial ownership arrangements are required by SEC regulation
to furnish to the Company copies of all such statements filed with the SEC.
The rules of the SEC regarding the filing of such statements require that
"late filings" of such statements be disclosed in the Company's information
statement. Based solely on the Company's review of copies of such statements
received by, and on representations from, the Company's existing directors
and officers that no annual statements of beneficial ownership were
required to be filed by such persons, the Company believes that all such
statements were timely filed in 2010.


				   12


BOARD MEETINGS AND COMMITTEES

Audit Committee and Audit Committee Financial Expert

Our Board of Directors functions as an audit committee and performs some of
the same functions as an audit committee including: (1) selection and
oversight of our independent accountant; (2) establishing procedures for the
receipt, retention and treatment of complaints regarding accounting, internal
controls and auditing matters; and (3) engaging outside advisors. We are not a
"listed company" under SEC rules and are therefore not required to have an
audit committee with independent directors. Our Board of Directors does not
have an independent director. Our Board of Directors has determined that each
of its members is able to read and understand fundamental financial statements
and has substantial relevant business and accounting experience. Accordingly,
the Board of Directors believes that each of its members has sufficient
knowledge and experience necessary to fulfill the duties and obligations that
an audit committee would have in a company such as ours.

Board Meetings; Nominating and Compensation Committees

Given the small size of the Company and its limited staff and operations,
its directors frequently make determinations informally by telephone calls
or by written consent.  The Board met before and after the Annual
Shareholders Meeting, and at one additional time during the Fiscal Year.
Each Meeting was attended by all directors.  We pay each of our Directors
a fixed annual stipend for acting as Director.  No such payment shall
preclude any director from serving us in any other capacity and receiving
compensation therefor. A total of $7,500 has been paid to each director for
services as director during the last fiscal year.


We are not a "listed company" under SEC rules and are therefore not required
to have a compensation committee or a nominating committee. We do not
currently have a compensation committee. Our Board of Directors is currently
comprised of only three members, one of whom acts as Chief Executive Officer
and Chief Financial Officer.

ITEM 11.     EXECUTIVE COMPENSATION

The following table sets forth certain summary information concerning
compensation paid or accrued to its sole executive officer during the past two
fiscal years.

SUMMARY COMPENSATION TABLE


        (a)             (b)      (c)       (d)         (e)          (f)

Name and               Fiscal  Salary($)  Bonus($)    All Other      Total
Principal Positions     Year     (1)                 Compensation*
Compensation
-------------------    ------  ---------  --------   ------------  -----------
-
Anderson L. McCabe      2010   $130,000   $25,000    $11,400       $166,400
President, CEO, CFO,    2009   $130,000   $15,000    $ 9,249       $154,249
Treasurer and Director

*Includes an annual retainer as Director of Company of $7,500 for 2010 and
$5,000 for 2009 in addition to a 401K Contribution of $3,900 for 2010 and
$4,249 for 2009.


				   13



OPTION/SAR GRANTS; DEFERRED EXECUTIVE COMPENSATION PLAN; EQUITY COMPENSATION
PLAN

The Company did not grant restricted stock awards, stock options or stock
appreciation rights during Fiscal Year 2010, nor does it have any of such
awards, options or rights outstanding from prior years. The Company does not
have any deferred executive compensation plan. The Company does not have any
securities authorized for issuance under an equity compensation plan.

DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR 2010

The following table sets forth the compensation of our non-employee directors.
Our employee director, Anderson L. McCabe, receives the same compensation as
the other directors for his services as director.  His director fees are
included in his total compensation in the Summary Compensation Table above.

Name                     Cash Retainer    Total Compensation

Arthur J. Kania            $ 7,500            $ 7,500*
Arthur J. Kania, Jr.       $ 7,500            $ 7,500

*Excludes payments for legal services to law firm of which Mr. Kania is a
partner. See Certain Transactions and Relationships below.

CODE OF ETHICS

The Company's Code of Ethics is posted at its website at optsciences.com.  It
applies to all employees, including the CEO, CFO, principal accounting officer
and persons performing similar functions.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

Beneficial ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or investment
power with respect to securities. The following table sets forth common stock
ownership information as of the record date with respect to (i)each person
known to us to be the beneficial owner of more than 5% of our issued and
outstanding common stock; and(ii)each of our directors and executive officers.

Name and Address of         Amount and Nature of     Percent of
Beneficial Owner              Beneficial Owner          Class

Arthur John Kania Trust 3/30/67     510,853              66%
Rose Sayen, Trustee
560 E. Lancaster Avenue, Suite 108
St. Davids, PA 19087-5049

Security Ownership of Directors and Officers:

Name and Address of         Amount and Nature of       Percent of
Beneficial Owner 	      Beneficial Owner           Class

Anderson L. McCabe	         1,064(1)                *
P.O. Box 221
1912 Bannard Street
Riverton, N.J. 08077


				   14



Arthur J. Kania		        23,723(1)               3%
560 E. Lancaster Avenue, Suite 108
St. Davids, PA 19087-5049

Arthur J. Kania, Jr.		     0(1)               *
560 E. Lancaster Avenue, Suite 108
St. Davids, PA 19087

Directors and Officers As a
Group                           24,787(1)               3%
*Less than 1% of the outstanding Common Stock

1.  Excludes 510,853 shares (66% of the outstanding shares) owned by a trust
for the benefit of Arthur J. Kania's children and a total of 10,000 shares
(1.3% of the outstanding shares) owned by separate trusts for the benefit of
each of Arthur J. Kania's grandchildren. Mr. Kania has no voting power or
investment power with respect to such securities and disclaims beneficial
ownership in all such shares. Mr. McCabe, husband of a beneficiary of the
first aforementioned trust, disclaims beneficial ownership in all such shares.
Arthur J. Kania, Jr., a son of Arthur J. Kania, is a beneficiary of the first
aforementioned trust and father of beneficiaries of the second aforementioned
trusts, but has no voting power and no investment power over such shares in
said trusts and is not a beneficial owner under the applicable rules.

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR
INDEPENDENCE

Arthur J. Kania is the father of Arthur J. Kania, Jr. and the father-in-law of
Anderson L. McCabe. Those individuals constitute the Board of Directors.
Anderson L. McCabe is the sole executive officer. Rose Sayen, an employee of
Arthur J. Kania, is the Trustee of the Arthur J. Kania Trust, which is the
principal shareholder of the Company.

During Fiscal year 2010, we incurred legal fees of $52,500 to the firm of
Kania, Lindner, Lasak and Feeney, of which Arthur J. Kania is the Senior
partner. Mr. Kania does not share or participate in fees generated from
the Company.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

       Type                 2009         2010

    Audit Fees:(1)        $34,470      $35,535
    Audit Related Fees:       -0-          -0-
    Tax Fees                  -0-          -0-
    Other Fees                -0-          -0-
                          -------      -------
    Total Fees            $34,470      $35,535

(1) AUDIT FEES

This category includes the aggregate fees billed or accrued for each of the
last two fiscal years for professional services rendered by the independent
auditors for the audit of the Company's annual financial statements and review
of financial statements included in the Company's Annual and Quarterly Reports
filed with the SEC or services that are normally provided by the accountant in
connection with other statutory and regulatory filings or engagements for
those fiscal years.


				15




(2) AUDIT-RELATED FEES

This category includes the aggregate fees billed in each of the last two
fiscal years for services by the independent auditors that are reasonably
related to the performance of the audits of the financial statements and are
not reported above under 'Audit Fees'.

(3) TAX FEES

This category includes the aggregate fees billed in each of the last two years
for professional services rendered by the independent auditors for tax
compliance, tax planning and tax advice.

(4) ALL OTHER FEES

This category includes the aggregate fees billed in each of the last two
fiscal years for products and services by the independent auditors that are
not reported under 'Audit Fees', 'Audit Related Fees', or 'Tax Fees.'

RE-APPROVAL POLICIES AND PROCEDURES

Before the accountant is engaged by the issuer to render audit or non-audit
services, the engagement is approved by the Company's Board of Directors
acting as the audit committee.

PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENTS SCHEDULES

The following exhibits are incorporated by reference or included as part of
this report:

Exhibit Number Description

3.1; 3.2  Articles of Incorporation and By-Laws incorporated by reference to
the Form 10-KSB filed by the registrant with the SEC on February 10, 1998 for
its fiscal year ended November 1, 1997 starting on page 22.

21. List of Subsidiaries incorporated by reference to the Form 10-KSB filed by
the registrant with the SEC on February 10, 1998 for its fiscal year ended
November 1, 1997 starting on page 54.

31. Certification pursuant to Section 302 of the Sarbanes Oxley Act included
as an exhibit to this Form 10K.

32. Certification pursuant to Section 906 of the Sarbanes Oxley Act included
as an exhibit to this Form 10K.

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.


OPT-SCIENCES CORPORATION

Date: January 25, 2011

By: /s/Anderson L. McCabe
      Anderson L. McCabe, President


				   16




Pursuant to the requirements of the Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.


   Signature                     Title                        Date

/s/ Anderson L. McCabe    President, CEO, CFO & Director  January 25, 2011
Anderson L. McCabe

/s/ Arthur J. Kania       Secretary & Director            January 25, 2011
Arthur J. Kania

/s/ Arthur J. Kania, Jr.  Director                        January 25, 2011
Arthur J. Kania, Jr.

/s/ Lorraine Domask       Chief Accountant                January 25, 2011
Lorraine Domask


				   17





Table of Contents
SECTION 302 CERTIFICATION

I, Anderson L. McCabe, President, Chief Executive Officer and Chief
Financial Officer, certify that:

1. I have reviewed this annual report on Form 10-K of OPT-SCIENCES
CORPORATION;

2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by
this annual report;

3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act
Rules 13a-15(b) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting or caused such
internal control over financial reporting to be designed under my
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report my conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and

d) Disclosed in this report  any  change in the registrant's internal
control over financial reporting that occurred during the registrant's
most recent fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrant's internal control over
financial reporting;

5. I have disclosed, based on my most recent evaluation of internal control
of financial reporting, to the registrant's auditors and the audit
committee of registrant's board of directors (or person performing the
equivalent functions):

   a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

   b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control
over financial reporting.

Date: January 25, 2011

By: /s/Anderson L. McCabe
Anderson L. McCabe
President, Chief Executive Officer and
Chief Financial Officer


				   18



SECTION 906 CERTIFICATION

I, Anderson L. McCabe, Chief Executive Officer and Chief Financial Officer of
OPT-SCIENCES CORPORATION (the "Company"), certify, pursuant to section 906 of
the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1) the Annual Report on Form 10K of the Company for the fiscal year ended
October 30, 2010 (the "Report') fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m
or 78o(d); and (2) the information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of
the Company for the periods presented.

Date: January 25, 2011

By: /s/Anderson L. McCabe
Anderson L. McCabe
President, Chief Executive Officer and
Chief Financial Officer


				   19










               OPT - Sciences Corporation And Subsidiary
                          Financial Statements

           Years Ended October 30, 2010 and October 31, 2009








                             TABLE OF CONTENTS


                                                           PAGE

Report of Independent Registered Public Accounting Firm	    21

Consolidated Balance Sheets	                            22

Consolidated Statements of Operations                       24

Consolidated Statements of
      Stockholders' Equity and Comprehensive Income	    25

Consolidated Statements of Cash Flows	                    26

Notes to Consolidated Financial Statements	            28


				   20










            Report of Independent Registered Public Accounting Firm


To Stockholders and Board of Directors
OPT-Sciences Corporation

We  have  audited  the  accompanying  consolidated  balance  sheets  of  OPT-
Sciences Corporation and Subsidiary as of October 30, 2010 and October 31,
2009 and the related statements of operations, stockholders' equity and
comprehensive income and cash flows for each of the fiscal years in the two
year period ended October 30, 2010.  These financial statements are the
responsibility of the Company's management.  Our responsibility is to express
an opinion on these financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (United States).  Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the
financial statements are free of material misstatement. The company is not
required to have, nor were we engaged to perform, an audit of its internal
control over financial reporting. Our audit included consideration of internal
control over financial reporting as a basis for designing audit procedures
that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the company's internal control
over financial reporting. Accordingly, we express no opinion.  An audit also
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation.  We believe that our audits provide
a reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the consolidated financial position of OPT-Sciences
Corporation and Subsidiary as of October 30, 2010 and October 31, 2009 and the
consolidated results of their operations and their cash flows for each of the
fiscal years in the two year period ended October 30, 2010 in conformity with
U.S. generally accepted accounting principles.



Goff, Backa, Alfera & company, LLC
Pittsburgh, Pennsylvania

January 25, 2011


				   21





                      Opt-Sciences Corporation
                     CONSOLIDATED BALANCE SHEETS
The accompanying notes are an integral part of these financial statements

                              ASSETS
                               October 30, 2010   October 31, 2009

CURRENT ASSETS
    Cash and cash equivalents      $ 8,398,276        7,606,849
    Trade accounts receivable          684,313          594,167
    Inventories                        634,247          558,609
    Prepaid expenses                    25,406           13,482
    Loans and exchanges                 12,543           10,058
    Prepaid income taxes                   -0-          138,200
    Marketable securities              502,809          469,468
        Total current assets        10,257,594        9,390,833

PROPERTY AND EQUIPMENT
    Land                               114,006          114,006
    Building and improvements          606,244          606,244
    Machinery and equipment          2,134,804        2,094,592
    Small tools                         53,580           53,580
    Furniture and fixtures              17,712           10,438
    Office equipment                    76,742           82,651
    Automobiles                         71,211           71,211
       Total property and equipment  3,074,299        3,032,722
       Less accumulated depreciation 2,110,104        1,950,701
       Net property and equipment      964,195        1,082,021

OTHER ASSETS
    Deposits                             2,837            2,837

       Total assets                $11,224,626      $10,475,691


				   22



                      Opt-Sciences Corporation
                     CONSOLIDATED BALANCE SHEETS
The accompanying notes are an integral part of these financial statements

                LIABILITIES AND STOCKHOLDERS' EQUITY

                               October 30, 2010   October 31, 2009
CURRENT LIABILITIES
    Accounts payable - trade       $    84,317      $    41,761
    Accrued income taxes               124,500              -0-
    Accrued salaries and wages         154,993          112,636
    Accrued professional fees           81,138           69,695
    Deferred income taxes               66,205           33,651
    Other current liabilities            4,280            2,310
       Total current liabilities       515,433          260,053

 STOCKHOLDERS' EQUITY
    Common capital stock - par value
      $.25 per share - authorized
      and issued 1,000,000 shares      250,000          250,000
    Additional paid in capital         272,695          272,695
    Retained earnings               10,401,501        9,940,851
    Accumulated other comprehensive
      income:
    Unrealized holding (loss)
      on marketable securities         (27,785)         (60,690)
    Less treasury stock at cost -
      224,415 shares                  (187,218)        (187,218)
         Total stockholders' equity 10,709,193       10,215,638

    Total liabilities and
      stockholders' equity         $11,224,626      $10,475,691


				   23




                      Opt-Sciences Corporation
                 CONSOLIDATED STATEMENTS OF INCOME
The accompanying notes are an integral part of these financial statements

                         Fiscal Year Ended  Fiscal Year Ended
                          October 30, 2010   October 31, 2009
                             (52 weeks)         (52 weeks)

NET SALES                    $4,899,983        $4,881,311
COST OF SALES                 3,444,311         3,611,895
Gross profit on sales         1,455,672         1,269,416
OPERATING EXPENSES
  Sales & delivery               26,159            26,178
  General and administrative    802,424           754,187
    Total operating expenses    828,583           780,365
Operating income                627,089           489,051
OTHER INCOME (LOSS)              75,293           (17,557)
    Net Income before taxes     702,382           471,494
FEDERAL AND STATE  INCOME TAXES 241,732           199,714
    Net income                  460,650           271,780
EARNINGS PER SHARE OF
  COMMON STOCK                      0.59             0.35
Weighted average number
  of shares                     775,585           775,585


				   24



                            Opt-Sciences Corporation
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY AND COMPREHENSIVE INCOME
The accompanying notes are an integral part of these financial statements


                                            Accumulated
                                            Other
             Common    Paid-in    Retained  Comprehensive  Treasury
             Stock     Capital    Earnings  Income         Stock      Total

BALANCE
NOVEMBER 2,
2008         $250,000  $272,695  $9,669,071  $(196,971)  $(187,218) $9,807,577

Net income
for fiscal
year ended
October 31,
2009                                271,780                            271,780

Unrealized
holding gains
on securities
arising during
period, net of tax
of $102,808     ______  ________   ________    136,281   _________     136,281

TOTAL COMPREHENSIVE INCOME                                             408,061

BALANCE
OCTOBER 31,
2009          $250,000  $272,695 $9,940,851  $ (60,690) $(187,218) $10,215,638

Net income for
fiscal year
ended October 30,
2010                                460,650                            460,650

Unrealized
holding gains
on securities
arising during
period, net of
tax of $24,823      _________ _______ _______   32,905    ________      32,905

TOTAL
COMPREHENSIVE
INCOME                                                                 493,555

BALANCE
OCTOBER 30,
2010         $250,000  $272,695 $10,401,501   $(27,785) $(187,218) $10,709,193


				   25






                         Opt-Sciences Corporation
                   CONSOLIDATED STATEMENTS OF CASH FLOWS
The accompanying notes are an integral part of these financial statements

                                    Fiscal Year Ended   Fiscal Year Ended
                                     October 30, 2010    October 31, 2009
                                         (52 weeks)         (52 weeks)

CASH FLOWS FROM OPERATING ACTIVITIES

Net income                              $   460,650             271,780
Adjustments to reconcile net income
  to net cash provided by
  operating activities:

  Depreciation                              159,403             192,821
  Loss on sale of securities                  4,166             148,269
  Deferred income taxes                       7,730              43,059
  Decrease (increase) in:
    Accounts receivable                     (90,146)            525,383
    Inventories                             (75,638)             52,571
    Prepaid expenses                        (11,924)              4,812
    Prepaid income taxes                    138,200            (138,200)
    Loans and exchanges                      (2,485)             (3,290)
  (Decrease) increase in:
    Accounts payable                         42,556            (161,521)
    Accrued income taxes                    124,500             (40,912)
    Accrued salaries and wages               42,357            (156,122)
    Accrued professional fees                11,443              19,195
    Other current liabilities                 1,970             (27,236)
    Net cash provided by operating
     activities                             812,782             730,609

CASH FLOWS FROM INVESTING ACTIVITIES
  Purchases of property and equipment       (41,577)           (341,430)
  Purchases of securities                    (4,778)            (66,999)
  Proceeds from sale of securities           25,000             358,669
    Net cash (used) by investing activities (21,355)            (49,760)


				   26




                         Opt-Sciences Corporation
                  CONSOLIDATED STATEMENTS OF CASH FLOWS
The accompanying notes are an integral part of these financial statements


                                    Fiscal Year Ended   Fiscal Year Ended
                                     October 30, 2010    October 31, 2009
                                         (52 weeks)         (52 weeks)

Increase in cash                        $   791,427        $   680,849
Cash and cash equivalents
  at beginning of period                  7,606,849          6,926,000
Cash and cash equivalents
  at end of period                      $ 8,398,276        $ 7,606,849

SUPPLEMENTAL DISCLOSURES:
  Interest paid                                 -0-                -0-
  Income taxes paid                     $    50,611        $   335,767


				   27




                OPT-Sciences Corporation and Subsidiary
              NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 -	Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of OPT-Sciences
Corporation and its wholly owned subsidiary.  All significant intercompany
accounts and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities and disclosure of
contingent assets and liabilities at the date of the financial statements and
the reported amounts of revenues and expenses during the reporting period.
Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers certificates of deposit and debt securities purchased
with a maturity of three months or less to be cash equivalents.

Line of Business and Credit Concentration

The Company, through its wholly owned subsidiary, is engaged in the business
of applying anti-reflective, conductive and/or other coatings to the
faceplates of instruments for aircraft cockpits.  The Company grants credit to
companies within the aerospace industry.

Accounts Receivable

Bad debts are charged to operations in the year in which the account is
determined to be uncollectible.  If the allowance method for doubtful accounts
were used, it would not have a material effect on the financial statements.

Inventories

Raw materials are stated at the lower of average cost or market.  Work in
process and finished goods are stated at accumulated cost of raw material,
labor and overhead, or market, whichever is lower.  Market is net realizable
value.


				   28





                OPT-Sciences Corporation and Subsidiary
              NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Marketable Securities

Marketable securities consist of debt and equity securities and mutual funds.
Equity securities include both common and preferred stock.

The Company's investment securities are classified as 'available-for-sale'.
Accordingly, unrealized gains and losses and the related deferred income tax
effects when material, are excluded from earnings and reported as a separate
component of stockholders' equity as accumulated other comprehensive income.
Realized gains or losses are computed based on specific identification of the
securities sold.

Property and Equipment

Property and equipment are comprised of land, building and improvements,
machinery and equipment, small tools, furniture and fixtures, office equipment
and automobiles.  These assets are recorded at cost.

Depreciation for financial statement purposes is calculated over estimated
useful lives of three to twenty-five years, using the straight-line method.

Maintenance and repairs are charged to expense as incurred.

Income Taxes

Deferred income taxes reflect the net tax effects of temporary differences
between the carrying amounts of assets and liabilities for financial reporting
purposes and the amounts used for income tax purposes.

Employee Benefit Plans

On October 1, 1998, the Company implemented a 401(k) profit sharing plan.  All
eligible employees of the Company are covered by the Plan.  Company
contributions are voluntary and at the discretion of the Board of Directors.
Company contributions were $29,371 and $33,616 for the years ended October
30, 2010 and October 31, 2009, respectively.

Earnings per Common Share

Earnings per common share were computed by dividing net income by the weighted
average number of common shares outstanding.

Revenue Recognition

The Company recognizes revenue from product sales in accordance with Financial
Accounting  Standards  Board  Accounting  Standards  Codification  Topic  605,
Revenue  Recognition  when  products  are  shipped and risk of  loss and
title has passed to the customer.

Consideration of Subsequent Events

These financial statements were approved and authorized for issue by the Board
of Directors on January 18, 2011.


				   29




               OPT-Sciences Corporation and Subsidiary
             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 2 - Inventories

Inventories


Inventories consisted of the
following:
                                            October 30,     October 31,
                                               2010            2009

Raw materials and supplies                   $175,014       $221,791
Work in progress                              334,370        182,607
Finished goods                                124,863        154,211


                                             $634,247       $558,609






NOTE 3- Marketable Securities

                                     Gross         Gross
                      Amortized    Unrealized    Unrealized    Fair
                         Cost        Gains          Losses     Value


October 30, 2010
 Common stock       $    28,578     $  1,284           -0-      29,862
 Preferred stock        237,567        5,834           -0-     243,401
 Mutual funds           285,409          -0-       (55,863)    229,546

                    $   551,554     $  7,118       (55,863)  $ 502,809


October 31, 2009
 Common stock       $    28,559          -0-        (4,952)     23,607
 Preferred stock        237,567          -0-       (25,279)    212,288
 Municipal bonds         40,000          -0-       (15,880)     24,120
 Mutual funds           269,816          -0-       (60,363)    209,453

                    $   575,942          -0-     $(106,474)  $ 469,468



Sales of securities available for sale during the years ended October 30,
2010 and October 31, 2009 were as follows:

                                       2010            2009

Proceeds from sales                $  25,000       $ 358,669

Gross realized gains               $     -0-       $  21,966

Gross realized losses              $   4,166       $ 170,235


				   30




               OPT-Sciences Corporation and Subsidiary
             NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


NOTE 4 -	Income Taxes

The income tax expense of the Company consists of the following:


                                    2010               2009
Current tax expense:

 Federal                        $  172,191         $   92,990

 State                              61,811             63,665

 Total                             234,002            156,655

Deferred tax expense:

 Federal                            (1,638)            55,303

 State                               9,368            (12,244)

 Total                               7,730             43,059

Income Tax Expense              $  241,732         $  199,714

At October 30, 2010, the Company had a deferred tax asset of $114,179 and a
deferred tax liability of $180,384, resulting in a net deferred tax liability
of $66,205.

At October 31, 2009, the Company had a deferred tax asset of $159,792 and a
deferred tax liability of $193,443, resulting in a net deferred tax liability
of $33,651.

Deferred income taxes result from significant temporary differences between
income for financial reporting purposes and taxable income.  These differences
arose principally from the use of accelerated tax depreciation and the carry
forward of capital and net operating losses.

At October 30, 2010, the Company had capital loss carry forwards of $219,160
expiring in 2011 through 2016.  All of these losses are deemed to be usable
before expiration.

During the year, amended tax returns were filed for the years 2006 through
2008 to take advantage of tax deductions not available at the time when
the returns were initially filed. As a result, the refunds received of
$44,542 reduced the income tax expense for the period and caused the
effective tax rate to drop from 42.4% to 33.9% for the years ended October
30, 2010 and October 31, 2009, respectively. Interest income was also
recognized on these refunds of $1,253.


				   31




                OPT-Sciences Corporation and Subsidiary
              NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 5 - 	Major Customers

Two customers accounted for $3,359,604 of net sales during the year ended
October 30, 2010.  The amount due from these customers, included in trade
accounts receivable, was $525,457 on October 30, 2010.

Two customers accounted for $3,044,045 of net sales during the year ended
October 31, 2009.  The amount due from these customers, included in trade
accounts receivable, was $386,877 on October 31, 2009.

NOTE 6 -	Concentration of Credit Risk of Financial Instruments

The Company has various demand and time deposits with financial institutions
where the amount of the deposits exceeds the federal insurance limits of the
institution on such deposits.  The maximum amount of accounting loss that
would be incurred if an individual or group that makes up the concentration of
the deposits failed completely to perform according to the terms of the
deposit was approximately $7,500,000 on October 30, 2010.

NOTE 7 - 	Related Party Transactions

During fiscal years 2010 and 2009, the Company incurred legal fees of $52,500
and $47,500, respectively to the firm of Kania, Lindner, Lasak and Feeney,
of which Mr. Arthur Kania, a shareholder and director, is senior partner.
Of the legal fees, $52,500 and $47,500 were included in accounts payable
at October 30, 2010 and October 31, 2009, respectively.


NOTE 8 - 	Fair Value Measurements

Effective January 1, 2008, the Company adopted FASB ASC Topic 820, Fair
Value Measurements and Disclosures, which, among other things, requires
enhanced disclosures about assets and liabilities carried at fair value.
FASB ASC Topic 820 establishes a hierarchal disclosure framework associated
with the level of pricing observability utilized in measuring assets and
liabilities at fair value.  There are three broad levels defined by FASB
ASC Topic 820 hierarchy.  The Company only has assets and liabilities falling
 under level I, in which quoted prices are available in active markets for
identical assets or liabilities as of the reported date.  See Note 3 above.




                                   32